weight loss medication not glp 1 Researchers move closer to matching patients with GLP-1 drug that works best for them Long-term Success of GLP-1s Hinges

How the Triple Agonist Works in Metabolic Research Retatrutide is a next-generation research peptide that simultaneously activates three separate metabolic receptors GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and GCG (Glucagon)

For instance, a randomized controlled trial published in the "Journal of Clinical Endocrinology & Metabolism" found that individuals treated with GLP-1 receptor agonists experienced greater weight loss compared to the control group

The peptide supports healthy connective tissue, which is found throughout your body

Together, CJC-1295 and Ipamorelin are used to stimulate the natural release of growth hormone from the pituitary gland

[ii] Holst JJ